CMR 2018 was again a major step forward for interventional MRI. CMR 2018 focused on the theme of “Improving Clinical Value by Technical Advances,” emphasizing the goal of both Societies to improve clinical outcomes in cardiovascular disease through innovation. This paved the way for a complete afternoon session with a line-up of speakers showing recent advances in their centers (e.g Dallas Childrens, RFH London, Helios Leipzig) and others (e.g. San Diego, NIH, Munich) pointing at the next indications to do in MRI. After SCMR 2017 in Washington also a live case of interventional MRI was broadcasted into the plenary meeting, this time from Kings College, London by Reza Rezavi. Notably, many American clinicians were happy that an FDA registered product is now available via Nano4Imaging. It was also clear from the meeting that a lot of our customers have to go through the same cumbersome pathway with hospital authorities, platform suppliers and many others. Nano4Imaging will launch a platform soon to share best practices and connect customers.